And compatible with previous reports [12, 17, 31], there are no pathological changes to heart, liver, lung or kidney in our study, demonstrating that VE-cadherin antagonists may act as effective anti-tumor drugs without affecting normal blood vessels. This evidence concerns the gene CDH5 and neoplasm.